Merit Medical Systems (MMSI) vs Penumbra (PEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Penumbra (PEN) has outperformed Merit Medical Systems (MMSI) over the past year, gaining 10.6% versus a loss of 3.3%. Over five years, MMSI leads with a +27.6% price change compared with +27.6% for PEN. Penumbra is the larger company by market cap ($12.58 billion vs $5.05 billion), about 2.5 times the size.
On valuation, Merit Medical Systems trades at a lower forward P/E (18.1x vs 53.1x for Penumbra). Penumbra converts more of its revenue into profit, with a net margin of 12.7% versus 8.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMSI | PEN |
|---|---|---|
| Share price | $84.34 | $319.12 |
| Market cap | $5.05B | $12.58B |
| 1-day change | -0.08% | -0.28% |
| YTD return | -4.31% | +2.64% |
| 1-year return | -3.28% | +10.63% |
| 5-year return | +27.58% | +27.57% |
| P/E ratio (TTM) | 31.59 | 80.38 |
| Forward P/E | 18.06 | 53.09 |
| EPS (TTM) | $2.67 | $3.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.52B | $1.40B |
| Revenue growth (YoY) | +11.75% | +17.50% |
| Net income (latest FY) | $128.49M | $177.69M |
| Gross margin | 48.70% | 67.14% |
| Operating margin | 12.19% | 13.48% |
| Net margin | 8.48% | 12.66% |
| 52-week high | $94.85 | $362.41 |
| 52-week low | $59.74 | $284.95 |
| Distance from 52-week high | -11.08% | -11.95% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +26.87% | +13.61% |
| Average volume | 656.91K | 358.21K |
| Shares outstanding | 59.92M | 39.41M |
| Employees | 7,500 | 4,700 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Penumbra is about 2.5 times larger than Merit Medical Systems by market value ($12.58B vs $5.05B).
- PEN has outperformed MMSI by 13.9 percentage points over the past year.
- Penumbra trades at a higher earnings multiple (80.4x vs 31.6x trailing P/E).
- Penumbra grew revenue faster in its latest fiscal year (+17.50% vs +11.75%).
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
About Penumbra
PEN stock →Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Health Care · Medical/Dental Instruments · 4,700 employees
MMSI vs PEN FAQ
Which is bigger, Merit Medical Systems or Penumbra?
Penumbra (PEN) is larger, with a market capitalization of $12.58B compared with $5.05B for Merit Medical Systems (MMSI).
Which stock has performed better over the past year, MMSI or PEN?
PEN returned +10.63% over the past 12 months, compared with -3.28% for MMSI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MMSI or PEN?
MMSI has the lower trailing P/E at 31.6, versus 80.4 for PEN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Merit Medical Systems and Penumbra in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.